The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows.Patients taking semag ...

Eli Lilly & Co. (NYSE:LLY) plans to start selling its popular weight-loss medication, Mounjaro, in Hong Kong by the end of ...

Learn how to grow your wealth through smart investing strategies and financial planning in this informative article by a ...

An Inverness woman is paying more than £200-a-month for medication to treat her Type 2 diabetes because doctors have told her ...

This report summarizes recent health news, covering Eli Lilly's Hong Kong approval for its weight-loss drug, a McDonald's E.

Pharmaceuticals’ New Drug Application #210934, for sotagliflozin oral tablet, as an adjunct to insulin therapy, to improve ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound despite the long-term threat to business.

Elizabeth Zachariah examines how the blockbluster success of Ozempic is shaping the global pharmaceutical landscape ...

In a remarkable study, it was found that a common vegetable could reduce high blood sugar levels by up to 50 percent ...

Semaglutide, the diabetes drug also known as Ozempic, has shown positive effects in treating patients with chronic kidney ...

Semaglutide may reduce Alzheimer's risk in type 2 diabetes patients, with research suggesting significant protective benefits ...